Clinicopathologic Characteristics and Prognostic Features of Well-Differentiated Pancreatic Neuroendocrine Tumors in MEN1 Syndrome: A Cohort Study of 39 MEN1 Patients and 778 Non-MEN1 Patients with 7752 Person-Year Follow-Up
Authors:
- Tiane ChenTCTiane Chen
- Amanda L. BlackfordABAmanda L. Blackford
- Ashley L. KiemanAKAshley L. Kieman
- Pedram ArganiPAPedram Argani
- Jin HeJHJin He
- Richard A. BurkhartRBRichard A. Burkhart
- William R. BurnsWBWilliam R. Burns
- John L. CameronJCJohn L. Cameron
- Kelly LafaroKelly Lafaro
- Christopher ShubertCSChristopher Shubert
- Günter KlöppelGKGünter Klöppel
- Atsuko KasajimaAKAtsuko Kasajima
Preprint
- 1 September 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Well-differentiated pancreatic neuroendocrine tumors (PanNETs) develop in ~80% of patients with multiple endocrine neoplasia type 1 (MEN1) and remain the leading cause of MEN1-related mortality. Whether MEN1-associated PanNETs display distinct clinicopathologic or prognostic characteristics compared with sporadic PanNETs remains incompletely defined. Methods: We retrospectively reviewed clinical, pathological, and outcome data from 817 patients who underwent surgical resection for well-differentiated PanNETs, including 39 MEN1-associated and 778 non-MEN1 tumors, with a total of 7,752 person-years of follow-up. Tumor characteristics, stage, and survival outcomes were compared between two groups. Results: MEN1-associated PanNETs represented 4.8% of the cohort and included both functional and non-functional tumors. Patients with MEN1 more frequently had functional tumors, with insulinomas and gastrinomas pre-dominating. Patients with MEN1 were significantly younger at surgery. Tumor size and grade distribution were similar between two groups, although tumors >2 cm were more prevalent in patients with MEN1. MEN1-associated tumors demonstrated significantly lower rates of lymphovascular and perineural invasion, but similar rates of lymph node metastasis and stage III disease when only lymph node metastases attributa-ble to a pancreatic primary were included. Long-term overall survival, disease-specific survival, and cumula-tive incidence of relapses did not differ significantly between MEN1 and non-MEN1 patients. Conclusions: Surgically resected MEN1-associated PanNETs show comparable histologic grade and tumor size to sporadic PanNETs. MEN1 is associated with more functional tumors and lymph node metastases, but less vascu-lar/perineural invasion. Despite these features, long-term overall survival, disease-specific survival and cu-mulative incidence of relapse are comparable between surgically resected patients with and without MEN1.Keywords
All Related Versions
- Version 1, 2026-09-01, Preprints
- Published version: Endocrines, 7 (4), 70.
This publication has 18 references indexed in Scilit:
- Surgical and Oncologic Outcomes After Pancreatectomy for Pancreatic Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 and von Hippel-Lindau Syndrome: A Large, Multi-Institutional, Cohort StudyJournal of the American College of Surgeons, 2026
- Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceThe Lancet Diabetes & Endocrinology, 2025
- Clinical aspects of multiple endocrine neoplasia type 1Nature Reviews Endocrinology, 2021
- Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1The Lancet Diabetes & Endocrinology, 2015
- Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patientsLaboratory Investigation, 2010
- Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 PatientsWorld Journal of Surgery, 2009
- Precursor Lesions in Patients With Multiple Endocrine Neoplasia Type 1--Associated Duodenal GastrinomasGastroenterology, 2005
- Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN 1Langenbeck's Archives of Surgery, 2002
- Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1Human Molecular Genetics, 1997
- Gastrinomas in the Duodenums of Patients with Multiple Endocrine Neoplasia Type 1 and the Zollinger-Ellison SyndromeNew England Journal of Medicine, 1990